Goa-based Molbio Diagnostics Limited, a leading company in molecular diagnostics backed by Temasek and Motilal Oswal Private Equity, has officially filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) to launch an initial public offering (IPO).
IPO Structure and Fund Utilization
As per the DRHP, the IPO will comprise:
- A fresh issue of equity shares worth up to ₹200 crore, and
- An offer-for-sale (OFS) of up to 1.25 crore shares by existing shareholders.
The company has outlined the following deployment of proceeds:
- ₹99.3 crore will be invested in building infrastructure for a new Research & Development (R&D) Centre, Centre of Excellence, and associated office space.
- ₹73.5 crore is earmarked for the procurement of plant and machinery at its manufacturing facilities in Goa and Visakhapatnam.
- The remainder will be allocated to general corporate purposes.
Company Overview
Founded in 2000, Molbio Diagnostics is a pioneer in point-of-care molecular diagnostics and currently offers solutions for more than 30 diseases such as tuberculosis, COVID-19, HIV, HPV, and Hepatitis B & C.
Its flagship innovation, the ‘Truenat’ platform, is a portable, battery-operated PCR device capable of delivering test results in under an hour, even in remote or resource-limited areas. The technology enjoys patent protection across more than 100 countries.
Molbio operates five manufacturing units:
- Two in Goa
- One in Visakhapatnam
- Two in Bengaluru (through its subsidiary Prognosys Medical Systems)
These facilities produce diagnostic devices, kits, and radiology equipment. As of March 31, 2025, the company’s annual installed capacity stood at 3,600 devices and 3.9 crore Truenat test kits.
Financial Performance
For the financial year FY25, Molbio Diagnostics reported:
- Revenue: ₹1,020 crore (a 22% YoY growth)
- Profit After Tax: ₹138.5 crore
This strong financial track record underscores Molbio’s growth momentum and expanding market presence in the diagnostics sector.
Book Running Lead Managers (BRLMs)
The IPO will be managed by top investment bankers, including:
- Kotak Mahindra Capital
- IIFL Capital Services
- Jefferies India
- Motilal Oswal Investment Advisors
Disclaimer: This article is intended solely for informational and educational purposes for readers of Legal Parivar. It should not be interpreted as investment, legal, or financial advice. Readers are strongly encouraged to consult qualified professionals or financial advisors before making any investment decisions regarding upcoming IPOs or stock market-related instruments.
